Clinical Trial
Clinical use of meptazinol
- PMID: 801579
Item in Clipboard
Clinical Trial
Clinical use of meptazinol
Acta Anaesthesiol Belg.
1976.
Abstract
Meptazinol, a new analgesic, was used at two different times of surgery: a) by the I.V. route peroperatively (1.6 mg/kg bodyweight with a maximum of 125 mg), b) by the I.M. route postoperatively (100 mg). When used I.V. peroperatively it does not seem to be a real progress, due to its poor neurovegetative protection and side-effects. However used I.M. postoperatively it seems a good analgesic drug with rapid onset and with few side effects.
Similar articles
-
Clinical assessment of oral meptazinol in postoperative pain.Acta Anaesthesiol Belg. 1976;27(3):159-70. Acta Anaesthesiol Belg. 1976. PMID: 801581 Clinical Trial.
-
Meptazinol--a new analgesic effects on hemodynamic stability.Acta Anaesthesiol Belg. 1976;27(3):151-8. Acta Anaesthesiol Belg. 1976. PMID: 801580 Clinical Trial. No abstract available.
-
Meptazinol: I.M. use in postoperative pain.Acta Anaesthesiol Belg. 1976;27 suppl:123-33. Acta Anaesthesiol Belg. 1976. PMID: 1015211
-
Meptazinol in the treatment of severe post-operative pain: a comparison with morphine.Postgrad Med J. 1983;59 Suppl 1:35-40. Postgrad Med J. 1983. PMID: 6403933 Clinical Trial.
-
Clinical review of parenteral meptazinol.Postgrad Med J. 1983;59 Suppl 1:85-92. Postgrad Med J. 1983. PMID: 6340086 Review.